# OnCo record paper-alk-nsclc-n-engl-j-med-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-alk-nsclc-n-engl-j-med-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-alk-nsclc-n-engl-j-med-2013" ;
  schema:name "Crizotinib versus chemotherapy in advanced ALK-positive lung cancer"@en ;
  schema:description "Phase 2 or 3 results paper on ALK in Non-small-cell lung cancer, in New England Journal of Medicine (2013), one of the most cited Europe PMC records with ALK in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-alk-nsclc-n-engl-j-med-2013/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1214886>, <https://pubmed.ncbi.nlm.nih.gov/23724913/>, <https://europepmc.org/article/MED/23724913> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1214886> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Shaw AT, Kim DW, Nakagawa K, et al." ;
  onco:journals <https://onco.cc/journals/nejm/> .